Logotype for Acutaas Chemicals Limited

Acutaas Chemicals (ACUTAAS) Q1 24/25 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Acutaas Chemicals Limited

Q1 24/25 earnings summary

10 Feb, 2026

Executive summary

  • Q1 FY25 revenue grew 16.6% year-over-year, primarily driven by advanced pharmaceutical intermediates and robust CDMO activity, with specialty chemicals growing 10% but Baba Fine Chemicals underperforming due to integration and demand issues.

  • Unaudited standalone and consolidated financial results for Q1 ended June 30, 2024, were approved by the Board and reviewed by statutory auditors with no modifications.

  • Q1 is historically the lowest revenue quarter, with sequential growth expected through the year and management reaffirming 25% annual growth guidance.

  • The company successfully completed PMDA (Japan) and USFDA inspections, enhancing regulatory credentials and opening new market opportunities.

Financial highlights

  • Q1 FY25 consolidated revenue: INR 176.7 crore (Rs. 1,767 mn), up 16.6% year-over-year; standalone revenue: ₹17,113.70 lakhs, up from ₹14,235.08 lakhs in Q1 FY24.

  • Gross profit: INR 74.3 crore, up 1% year-over-year; gross margin at 42.1%, down from 47.9% in Q1 FY24 but up from 40% in Q4 FY24.

  • EBITDA: INR 29.5 crore, down 13.2% year-over-year; EBITDA margin at 16.7%, down from 22.1% last year.

  • PAT for Q1 FY25 was INR 14.7 crore, with a PAT margin of 8.3%, impacted by increased finance and depreciation costs.

  • Net cash on hand as of June: INR 385 crore; net debt zero status achieved after raising Rs. 500 crore and repaying Rs. 253 crore debt.

Outlook and guidance

  • Management reaffirms 25% revenue growth guidance for FY 2025, with sequential improvement expected in coming quarters based on the current order book.

  • EBITDA margin expected to improve by 200 basis points in subsequent quarters due to operational leverage and margin normalization.

  • Full ramp-up of new CDMO contracts and Ankleshwar blocks expected by FY 2026.

  • Tax rate for FY 2025 expected to be slightly above 25%.

  • Proceeds from recent equity issues are earmarked for growth and operational objectives, with significant unutilized funds in fixed deposits.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more